サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1746825

日本のウィメンズヘルス診断市場レポート：タイプ、用途、エンドユーザー、地域別、2025年～2033年

Japan Women's Health Diagnostics Market Report by Type, Application, End User, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 117 Pages
納期
5～7営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.08円
日本のウィメンズヘルス診断市場レポート：タイプ、用途、エンドユーザー、地域別、2025年～2033年
出版日: 2025年06月02日
発行: IMARC
ページ情報: 英文 117 Pages
納期: 5～7営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

日本のウィメンズヘルス診断市場規模は2024年に16億米ドルに達しました。今後、IMARC Groupは、2033年には33億米ドルに達し、2025～2033年の成長率（CAGR）は7.5％になると予測しています。小型化された診断機器や家庭用検査キットの普及が、主に市場成長の原動力となっています。

本レポートで扱う主な質問

  • 日本のウィメンズヘルス診断市場はこれまでどのように推移し、今後どのように推移するのか？
  • COVID-19が日本のウィメンズヘルス診断市場に与えた影響は？
  • 日本のウィメンズヘルス診断市場のタイプ別内訳は？
  • 日本のウィメンズヘルス診断市場の用途別内訳は？
  • 日本のウィメンズヘルス診断市場のエンドユーザー別内訳は？
  • 日本のウィメンズヘルス診断市場のバリューチェーンにおける様々なステージとは？
  • 日本のウィメンズヘルス診断の主要な促進要因と課題は何か？
  • 日本のウィメンズヘルス診断市場の構造と主要プレーヤーは？
  • 日本のウィメンズヘルス診断市場における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
  • 市場推定
  • 調査手法

第3章 エグゼクティブサマリー

第4章 日本のウィメンズヘルス診断市場- イントロダクション

  • 概要
  • 市場力学
  • 業界動向
  • 競合情報

第5章 日本のウィメンズヘルス診断市場情勢

  • 過去および現在の市場動向（2019～2024年）
  • 市場予測（2025～2033年）

第6章 日本のウィメンズヘルス診断市場- タイプ別内訳

  • 診断装置
  • 診断検査

第7章 日本のウィメンズヘルス診断市場- 用途別内訳

  • 乳がん
  • 感染症検査
  • 骨粗鬆症検査
  • 妊娠と生殖能力の検査
  • 性感染症検査
  • その他

第8章 日本のウィメンズヘルス診断市場- エンドユーザー別内訳

  • 病院および診断センター
  • 在宅ケア

第9章 日本のウィメンズヘルス診断市場- 競合情勢

  • 概要
  • 市場構造
  • 市場企業のポジショニング
  • 主要成功戦略
  • 競合ダッシュボード
  • 企業評価象限

第10章 主要企業のプロファイル

第11章 日本のウィメンズヘルス診断市場- 業界分析

  • 促進要因・抑制要因・機会
  • ポーターのファイブフォース分析
  • バリューチェーン分析

第12章 付録

目次
Product Code: SR112025A18577

Japan women's health diagnostics market size reached USD 1.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.3 Billion by 2033, exhibiting a growth rate (CAGR) of 7.5% during 2025-2033. The elevating adoption of miniaturized diagnostic devices and test kits for home use is primarily driving the market growth.

Women's health diagnostics play a crucial role in diagnosing a wide range of biological and psychosocial conditions affecting female patients. These diagnostics aid in the identification and management of issues related to sexuality, vaginal health, pregnancy complications, and serious illnesses such as osteoporosis, menopause, as well as specific cancers like breast and cervical cancer. They utilize advanced laboratory tests, medical equipment, and procedures, which encompass biopsy, ultrasound, chemotherapy, and magnetic resonance imaging (MRI). Many healthcare diagnostic centers now provide an extensive array of laboratory testing solutions to improve the diagnosis and treatment of rare diseases and conditions that predominantly affect women.

Japan Women's Health Diagnostics Market Trends:

The increasing prevalence of health issues affecting the overall well-being of women is a key driving force in the Japan market. Additionally, the growing awareness of the benefits of early diagnosis and a heightened sense of health consciousness are boosting the demand for point-of-care (POC) women's health diagnostics, which is acting as another significant growth-inducing factor. Furthermore, the rising rates of infertility due to stressful lifestyles and increased alcohol and drug consumption are fueling the need for women's health diagnostics to address pregnancy complications and promote healthier lives. Moreover, as menopause can raise the risk of certain medical conditions such as cardiovascular diseases and urinary incontinence, the significant increase in the female population is contributing to market growth. Apart from this, various research studies have indicated that women are more susceptible to psychiatric disorders like depression and anxiety during hormonal changes. This, coupled with initiatives by health agencies in numerous countries to improve women's mental health, is driving market expansion. As such, numerous prominent companies are working on the creation of state-of-the-art diagnostic and imaging devices that are both minimally invasive and capable of delivering quicker and improved diagnostic outcomes. These factors are projected to fuel the regional market in the coming years.

Japan Women's Health Diagnostics Market Segmentation:

Type Insights:

  • Diagnostic Devices
    • Biopsy Device
    • Imaging and Monitoring Devices
    • Accessories and Consumables
  • Diagnostic Tests
    • Breast Cancer Testing
    • PAP Smear and HPV Test
    • Pregnancy Testing and Ovulation Testing
    • Others

Application Insights:

  • Breast Cancer
  • Infectious Disease Testing
  • Osteoporosis Testing
  • Pregnancy and Fertility Testing
  • Sexually Transmitted Disease Testing
  • Others

End User Insights:

  • Hospital and Diagnostics Centers
  • Home Care

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan women's health diagnostics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan women's health diagnostics market?
  • What is the breakup of the Japan women's health diagnostics market on the basis of type?
  • What is the breakup of the Japan women's health diagnostics market on the basis of application?
  • What is the breakup of the Japan women's health diagnostics market on the basis of end user?
  • What are the various stages in the value chain of the Japan women's health diagnostics market?
  • What are the key driving factors and challenges in the Japan women's health diagnostics?
  • What is the structure of the Japan women's health diagnostics market and who are the key players?
  • What is the degree of competition in the Japan women's health diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Women's Health Diagnostics Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Women's Health Diagnostics Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Women's Health Diagnostics Market - Breakup by Type

  • 6.1 Diagnostic Devices
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Segmentation
      • 6.1.3.1 Biopsy Device
      • 6.1.3.2 Imaging and Monitoring Devices
      • 6.1.3.3 Accessories and Consumables
    • 6.1.4 Market Forecast (2025-2033)
  • 6.2 Diagnostic Tests
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Segmentation
      • 6.2.3.1 Breast Cancer Testing
      • 6.2.3.2 PAP Smear and HPV Test
      • 6.2.3.3 Pregnancy Testing and Ovulation Testing
      • 6.2.3.4 Others
    • 6.2.4 Market Forecast (2025-2033)

7 Japan Women's Health Diagnostics Market - Breakup by Application

  • 7.1 Breast Cancer
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 Infectious Disease Testing
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)
  • 7.3 Osteoporosis Testing
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2019-2024)
    • 7.3.3 Market Forecast (2025-2033)
  • 7.4 Pregnancy and Fertility Testing
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2019-2024)
    • 7.4.3 Market Forecast (2025-2033)
  • 7.5 Sexually Transmitted Disease Testing
    • 7.5.1 Overview
    • 7.5.2 Historical and Current Market Trends (2019-2024)
    • 7.5.3 Market Forecast (2025-2033)
  • 7.6 Others
    • 7.6.1 Historical and Current Market Trends (2019-2024)
    • 7.6.2 Market Forecast (2025-2033)

8 Japan Women's Health Diagnostics Market - Breakup by End User

  • 8.1 Hospital and Diagnostics Centers
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2019-2024)
    • 8.1.3 Market Forecast (2025-2033)
  • 8.2 Home Care
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2019-2024)
    • 8.2.3 Market Forecast (2025-2033)

9 Japan Women's Health Diagnostics Market - Competitive Landscape

  • 9.1 Overview
  • 9.2 Market Structure
  • 9.3 Market Player Positioning
  • 9.4 Top Winning Strategies
  • 9.5 Competitive Dashboard
  • 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

  • 10.1 Company A
    • 10.1.1 Business Overview
    • 10.1.2 Product Portfolio
    • 10.1.3 Business Strategies
    • 10.1.4 SWOT Analysis
    • 10.1.5 Major News and Events
  • 10.2 Company B
    • 10.2.1 Business Overview
    • 10.2.2 Product Portfolio
    • 10.2.3 Business Strategies
    • 10.2.4 SWOT Analysis
    • 10.2.5 Major News and Events
  • 10.3 Company C
    • 10.3.1 Business Overview
    • 10.3.2 Product Portfolio
    • 10.3.3 Business Strategies
    • 10.3.4 SWOT Analysis
    • 10.3.5 Major News and Events
  • 10.4 Company D
    • 10.4.1 Business Overview
    • 10.4.2 Product Portfolio
    • 10.4.3 Business Strategies
    • 10.4.4 SWOT Analysis
    • 10.4.5 Major News and Events
  • 10.5 Company E
    • 10.5.1 Business Overview
    • 10.5.2 Product Portfolio
    • 10.5.3 Business Strategies
    • 10.5.4 SWOT Analysis
    • 10.5.5 Major News and Events

11 Japan Women's Health Diagnostics Market - Industry Analysis

  • 11.1 Drivers, Restraints, and Opportunities
    • 11.1.1 Overview
    • 11.1.2 Drivers
    • 11.1.3 Restraints
    • 11.1.4 Opportunities
  • 11.2 Porters Five Forces Analysis
    • 11.2.1 Overview
    • 11.2.2 Bargaining Power of Buyers
    • 11.2.3 Bargaining Power of Suppliers
    • 11.2.4 Degree of Competition
    • 11.2.5 Threat of New Entrants
    • 11.2.6 Threat of Substitutes
  • 11.3 Value Chain Analysis

12 Appendix